News - Mergers & Acquisitions


Current filters:

Mergers & Acquisitions

Popular Filters

826 to 850 of 898 results

Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida


Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business


Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million


UK specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) says it has disposed of the epilepsy drug Mysoline…

Laboratoires SERBMergers & AcquisitionsMysolineNeurologicalPharmaceuticalSinclair IS Pharma

Angiotech opts out of cardiovascular cell therapy program with Athersys


Regenerative medicines firm Athersys (Nasdaq: ATHX) says that Canada’s Angiotech Pharmaceuticals…

AngiotechAthersysBiotechnologyFinancialLicensingMergers & Acquisitions

Invida acquires portfolio of derma and primary care products from Shalaks for marketing in India


Singapore-headquartered Invida Holdings, a leading specialty biopharmaceutical company focused on the…

Asia-PacificDermatologicalsInvidaMergers & AcquisitionsPharmaceuticalShalaks Pharma

STADA to buy Spirig generics business for $109 million; posts 9-month loss due to Serbian difficulties


German drugmaker STADA Arzneimittel (SAZ: GR) has reached agreement with Switzerland’s Spirig Pharma…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSpirig PharmaSTADA Arzneimittel

Japanese pharma companies set to go global - by P Reed Maurer


In a short time much can change in Japan. A striking example is the move by Japanese pharmaceutical companies…

Asia-PacificLicensingMergers & AcquisitionsPharmaceutical

Salix Pharma to buy Oceana for $300 million; posts 3rd-qtr profit


With the aim of improving its innovate products franchise, US drugmaker Salix Pharmaceuticals (Nasdaq:…

FinancialMergers & AcquisitionsOceana TherapeuticsPharmaceuticalSalix Pharmaceuticals

Synthes acquisition by Johnson & Johnson delayed as EU Commission starts in-depth investigation


The planned $21.3 billion acquisition of orthopedic device maker Synthes (SYST: VX), which is listed…

Johnson & JohnsonMergers & AcquisitionsPharmaceuticalSynthes

Ipsen sells North American rights for Apokyn to Britannia Pharma


French drugmaker Ipsen (Euronext: IPN) today has sold its North American development and marketing rights…

ApokynBritannia PharmaceuticalsIpsenMergers & AcquisitionsNeurologicalPharmaceuticalSTADA Arzneimittel

SurModics to sell pharmaceutical assets to Evonik for $30 million


USA-based SurModics (Nasdaq: SRDX), a provider of surface modification technologies to the healthcare…

Evonik InternationalMergers & AcquisitionsPharmaceuticalSurModics

Sanofi to top Pfizer as number one for global pharma sales


French drug major Sanofi (Euronext: SAN) is expected to take the top spot amongst the world’s pharmaceuticals…

FinancialGlobalJohnson & JohnsonMarkets & MarketingMerck & CoMergers & AcquisitionsNovartisNovo NordiskPfizerPharmaceuticalSanofiTakeda PharmaceuticalsTeva Pharmaceutical Industries

ViroPharma to acquire DuoCort Pharma for up to $164 million, adding European orphan drug to pipeline


The USA’s ViroPharma (Nasdaq: VPHM) says it has signed a definitive agreement to acquire DuoCort…

DuoCort PharmaMergers & AcquisitionsPharmaceuticalPlenadrenRare diseasesViroPharma

Repligen to buy Novozymes Biopharma Sweden business for $23 upfront; Biotie pulls out of Newron acquisition


USA-based Repligen (Nasdaq: RGEN) says it has signed a definitive agreement to acquire the business of…

Biotie TherapiesMergers & AcquisitionsNewron PharmaNovozymesPharmaceuticalRepligensafinamide

Karo Bio to spin off preclinical development


In order to achieve better allocation of resources and competences, Swedish biotech firm Karo Bio (STO:…

BiotechnologyKaro BioMergers & AcquisitionsResearch

Biostar Pharma sets out targets as it completes buy of Shaanxi Weinan


Chinese drugmaker Biostar Pharmaceuticals (Nasdaq: BSPM) says that it has completed the previously-announced…

Asia-PacificBiostar PharmaGenericsMergers & AcquisitionsShaanxi Weinan

WuXi PharmaTech acquires China-based clinical services companies; ShangPharma buys Charles River research facility


WuXi PharmaTech (NYSE: WX) says it has acquired MedKey Med-Tech Development and Jiecheng Med-Tech Development,…

BiotechnologyCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalShangPharmaWuXi Apptec

Arrowhead acquires RNA assets and site from Roche, which takes minority stake in the firm


California, USA-based Arrowhead Research Corp Nasdaq: ARWR) said yesterday that it has acquired RNA therapeutics…

Arrowhead ResearchFinancialMergers & AcquisitionsPharmaceuticalRoche

Ferring Pharma acquires Cytokine PharmaSciences; Cubist buys Adolor


Switzerland-based Ferring Pharmaceuticals says that it has completed the purchase of USA-based Cytokine…

AdolorCubist PharmaceuticalsCytokine PharmaSciencesEnteregFerring PharmaceuticalsGastro-intestinalsMergers & AcquisitionsPharmaceuticalReproductive

Immdal sells Newport to Ewopharma; establishes Immcell


Privately-held Irish drugmaker Immdal last week announced the sale of its subsidiary Newport Pharmaceuticals…

Anti-viralsEwopharmaImmdalMergers & AcquisitionsNewport PharmaPharmaceutical

Rainbow Coral seeks place in $84.6 billion biotechnology sector, forming new division; AMAG merger with Allos called off


Florida, USA-based Rainbow Coral (OTCQB: RBCC) last week announced its intention to move into the discovery…

Allos TherapeuticsAMAG PharmaceuticalsBiotechnologyMergers & AcquisitionsPharmaceuticalRainbow BiosciencesResearch

Sun Pharma offers to acquire remainder of Taro shares


Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

GlaxoSmithKline may be ready to acquire Human Genome, newspaper reports


Shares of the UK’s biggest pharmaceuticals group, GlaxoSmithKline (LSE: GSK) amid revived speculation…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Angel Biotech proposes joint venture with Russia’s Materia Medica


Scotland-based Angel Biotechnology (ABH: LON) saw its shares leap 20% to 0.28 pence on Monday after it…

Angel BiotechnologyBiotechnologyEuropeMateria MedicaMergers & Acquisitions

826 to 850 of 898 results

Back to top